Dr. Kishore has about 40 years of research experience in renal physiology, pathophysiology and experimental therapeutics gained in India, Japan, Beligum and the United States, which includes the Intramural Research Program of the National Heart, Lung and Blood Institute, NIH, Bethesda, Maryland. His research focused on the role of purinergic signaling in the genesis of clinically relevant water balance disorders, diet-induced obesity and insulin resistance, and vasopressin excessive states, such as cirrhosis of liver, autosomal dominant polycystic kidney disease (ADPKD) and others. Dr. Kishore and his collaborators identified and filed patents for novel drug targets for the treatment of acquired NDI and diet-induced obesity, and vasopressin excessive states. In addition, Dr. Kishore and his collaborators developed and patented a novel method to induce proliferation of erythropoietin (EPO)-producing cells in the kidney. Over the years, Dr. Kishore's research has been funded by the Department of Veterans Affairs, National Institute of Diabetes and Digestive and Kidney Diseases, National Foundation of Utah & Idaho, University of Utah Research Foundation, Western Institute for Biomedical Research and Eye Foundation of America.
- Vasopressin Excessive States
- Role of Purinergic Signaling in Diet-induced Obesity
- Tubulointerstitial Reactions
- Renal Physiology
- Purinergic Regulation of Renal Water and Sodium Transport in Health and Disease
- Polyuric Acute Renal Failure
- Pathophysiology of Acute and Chronic Renal Failure
- Pathophysiology of Acquired Nephrogenic Diabetes Insipidus
- Induction of Native Erythropoietin Production in the Kidney
Publications - PubMed
- English, fluent.
- Telugu, fluent.
- Hindi, fluent.
- French, functional.
Geographical Regions of Interest
- United States of America
- United Kingdom of Great Britain and Northern Ireland
- New Zealand